Trial Profile
Safety of Intravenous Thrombolytics in Stroke on Awakening
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Alteplase (Primary)
- Indications Embolism and thrombosis; Stroke
- Focus Adverse reactions
- Acronyms SAIL-ON
- 05 Mar 2017 Status changed from recruiting to completed.
- 16 Jan 2014 As per ClinicalTrials.gov record planned end date changed from 1 Jul 2014 to 1 Dec 2014.
- 28 Jan 2013 Planned End Date changed from 1 Sep 2014 to 1 Jul 2014 as reported by ClinicalTrials.gov.